Russell Investments Group, Ltd. Puma Biotechnology, Inc. Transaction History

Russell Investments Group, Ltd.

$84.2 Billion
Q3 2025

A detailed history of Russell Investments Group, Ltd. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 964,693 shares of PBYI stock, worth $4.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

964,693

Previous 20 4823365.0%

Holding current value

$4.78 Million

Previous $0 Infinity%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.07 - $5.73 $2.96 Million - $5.53 Million	964,673 Added 4823365.0%	964,693 $4.95 Million
Q2 2025 Aug 13, 2025	SELL	$2.74 - $3.72 $57,192 - $77,647	-20,873 Reduced 99.9%	20 $0
Q1 2025 May 13, 2025	BUY	$2.76 - $3.88 $57,609 - $80,987	20,873 Added 104365.0%	20,893 $61,000
Q2 2024 Aug 08, 2024	BUY	$2.92 - $5.83 $58 - $116	20 New	20 $0
Q3 2022 Nov 04, 2022	SELL	$2.27 - $3.84 $47,579 - $80,486	-20,960 Reduced 17.45%	99,139 $234,000

Q2 2022 Jul 29, 2022	SELL	$1.64 - $3.3 $86,318 - $173,688	-52,633 Reduced 30.47%	120,099 $342,000
Q1 2022 May 05, 2022	BUY	$2.13 - $3.24 $161,477 - $245,627	75,811 Added 78.22%	172,732 $497,000
Q4 2021 Jan 21, 2022	SELL	$2.85 - $6.58 $757,387 - $1.75 Million	-265,750 Reduced 73.28%	96,921 $293,000
Q3 2021 Nov 08, 2021	BUY	$6.63 - $9.39 $2.31 Million - $3.28 Million	348,963 Added 2545.69%	362,671 $2.54 Million
Q2 2021 Aug 04, 2021	SELL	$8.98 - $11.6 $1.04 Million - $1.34 Million	-115,721 Reduced 89.41%	13,708 $125,000
Q1 2021 May 10, 2021	SELL	$9.38 - $13.63 $154,573 - $224,608	-16,479 Reduced 11.29%	129,429 $1.23 Million
Q4 2020 Feb 08, 2021	SELL	$7.78 - $12.13 $322,815 - $503,310	-41,493 Reduced 22.14%	145,908 $1.51 Million
Q3 2020 Nov 09, 2020	BUY	$9.5 - $11.14 $468,920 - $549,870	49,360 Added 35.76%	187,401 $1.88 Million
Q2 2020 Aug 05, 2020	BUY	$7.01 - $13.24 $449,404 - $848,803	64,109 Added 86.71%	138,041 $1.42 Million
Q1 2020 May 06, 2020	SELL	$6.28 - $14.57 $20,994 - $48,707	-3,343 Reduced 4.33%	73,932 $623,000
Q4 2019 Jan 29, 2020	BUY	$6.5 - $10.73 $292,890 - $483,493	45,060 Added 139.87%	77,275 $670,000
Q3 2019 Nov 01, 2019	BUY	$8.75 - $12.85 $281,881 - $413,962	32,215 New	32,215 $360,000
Q1 2019 May 13, 2019	SELL	$20.77 - $42.37 $238,024 - $485,560	-11,460 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$20.07 - $46.7 $11,801 - $27,459	588 Added 5.41%	11,460 $233,000
Q3 2018 Oct 26, 2018	SELL	$41.2 - $59.85 $143,540 - $208,517	-3,484 Reduced 24.27%	10,872 $498,000
Q2 2018 Aug 08, 2018	SELL	$48.3 - $68.25 $131,762 - $186,186	-2,728 Reduced 15.97%	14,356 $849,000
Q1 2018 May 11, 2018	BUY	$59.7 - $99.25 $20,357 - $33,844	341 Added 2.04%	17,084 $1.16 Million
Q4 2017 Feb 06, 2018	SELL	$93.85 - $132.45 $851,594 - $1.2 Million	-9,074 Reduced 35.15%	16,743 $1.67 Million
Q3 2017 Nov 07, 2017	BUY	$72.0 - $119.75 $1.86 Million - $3.09 Million	25,817	25,817 $3.09 Million

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Puma Biotechnology, Inc. Transaction History